Aclaris Therapeutics (ACRS) Other financing activities (2016 - 2026)
Aclaris Therapeutics' (ACRS) quarterly Other financing activities came in at $151000.0 in Q1 2026, up 208.16% quarter-over-quarter from $49000.0 in Q4 2023.
Aclaris Therapeutics (ACRS) Other financing activities (2016 - 2026) Analysis & Trends
Aclaris Therapeutics' Other financing activities history runs 9 years deep, the most recent figure standing at $151000.0 for Q1 2026.
- On a quarterly basis, Other financing activities changed N/A year-over-year to $151000.0 in Q1 2026; TTM through Mar 2026 was $215000.0, a N/A change from a year earlier, with the FY2024 full-year figure at $32000.0, down 65.96% from the prior year.
- Other financing activities climbed to $151000.0 in Q1 2026 per ACRS's latest filing, from $49000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $151000.0 in Q1 2026 and bottomed at $15000.0 in Q3 2023.
- The 3-year median for Other financing activities is $43000.0 (2022), against an average of $62000.0.
- Across the five-year window, Other financing activities plunged 92.04% in 2022 and jumped 32.43% in 2023, its largest moves.
- Year by year, Other financing activities stood at $37000.0 in 2022, then soared by 32.43% to $49000.0 in 2023, then jumped by 208.16% to $151000.0 in 2026.
- Per Business Quant, the three latest ACRS Other financing activities figures stand at $151000.0 (Q1 2026), $49000.0 (Q4 2023), and $15000.0 (Q3 2023).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Aclaris Therapeutics | 705.88 Mn | 705.88 Mn | 1.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 151,000.00 |
| Mar 31, 2026 | 151,000.00 |
| Dec 31, 2023 | 49,000.00 |
| Dec 31, 2023 | 49,000.00 |
| Sep 30, 2023 | 15,000.00 |
| Sep 30, 2023 | 15,000.00 |
| Dec 31, 2022 | 37,000.00 |
| Dec 31, 2022 | 37,000.00 |
| Jun 30, 2022 | 83,000.00 |
| Jun 30, 2022 | 83,000.00 |
| Mar 31, 2022 | 37,000.00 |
| Mar 31, 2022 | 37,000.00 |
| Jun 30, 2021 | 1.04 Mn |
| Jun 30, 2021 | 1.04 Mn |
| Mar 31, 2021 | 416,000.00 |
| Mar 31, 2021 | 416,000.00 |
| Mar 31, 2020 | 25,000.00 |
| Mar 31, 2020 | 25,000.00 |
| Dec 31, 2019 | 122,000.00 |
| Dec 31, 2019 | 122,000.00 |